Skip to search formSkip to main contentSkip to account menu

TAP-144

Known as: TAP 144, TAP144 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
TAP-144-SR (3M) is a 3-month sustained releasing injection of a super-active agonist of luteinizing hormone releasing hormone (LH… 
2002
2002
A randomized, multicenter, double-blind, parallel-group study was conducted in order to evaluate the hormonal kinetics… 
1996
1996
Although it is well recognized that continuous administration of gonadotropin-releasing hormone agonist (GnRHa) induces pituitary… 
1991
1991
SummaryThe cytotoxic effect of cis-diamminedichloro-platinum II (cisplatin, CDDP) on spermatogenesis in BALB/C mice, and possible… 
1990
1990
The paradoxical effects of TAP-144-SR, a biodegradable sustained-release formulation of a potent GnRH agonist (TAP-144… 
1989
1989
The effects of Gn-RH and its agonists on the activity of aromatase were examined by means of a rat granulosa cell culture system… 
1984
1984
A highly potent LHRH agonist, des-Gly10-[D-Leu6]-LHRH-ethylamide (TAP-144), was administered by subcutaneous, vaginal, rectal and…